Skip to main content
. Author manuscript; available in PMC: 2018 Feb 20.
Published in final edited form as: Contemp Clin Trials Commun. 2017 Jun 24;7:136–140. doi: 10.1016/j.conctc.2017.06.011

Table 1.

Potential patients from the ADVANCE data for inclusion in the study.

Total
N = 950,304
Expansion statesa
(n = 584,282)
Non-expansion statesb
(n = 366,022)
All patients
(n = 576,711)
Cancer survivors
(n = 7571)
All patients
(n = 361,421)
Cancer survivors
(n = 4601)

% % % %
Sex
 Men 39.9 35.1 35.5 33.4
 Women 60.1 64.9 64.5 66.6
Age in years
 20–44 61.0 21.5 57.7 28.0
 45–64 39.0 78.5 42.3 72.0
Race/ethnicity
 White 55.3 65.7 29.2 42.8
 Black 10.0 6.3 30.7 24.5
 Other 4.5 3.6 2.1 1.6
 Hispanic 26.8 21.0 35.8 29.5
 Missing 3.4 3.4 2.1 1.6
Insurance Type
 Medicaid 23.3 31.0 13.0 22.0
 Private 21.2 25.7 14.5 18.1
Insurance Status
 Uninsured 50.2 29.2 69.7 51.8

Data from 2012–2015.

a

Expanded Medicaid as of 10/1/2016 14 states (AK, CA, HI, IN, MA, MD, MN, MT, NM, NV, OH, OR, RI, and WA) and 374 community health centers.

b

Did not expand Medicaid as of 10/1/2016 6 states (FL, KS, MO, NC, TX, and WI) and 299 community health centers.